Assessment  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
tissue  ||| S:14 E:21 ||| NN
oxygen  ||| S:21 E:28 ||| NN
saturation  ||| S:28 E:39 ||| NN
during  ||| S:39 E:46 ||| IN
a  ||| S:46 E:48 ||| DT
vascular  ||| S:48 E:57 ||| JJ
occlusion  ||| S:57 E:67 ||| JJ
test  ||| S:67 E:72 ||| NN
using  ||| S:72 E:78 ||| VBG
near-infrared  ||| S:78 E:92 ||| JJ
spectroscopy ||| S:92 E:104 ||| NN
:  ||| S:104 E:106 ||| :
the  ||| S:106 E:110 ||| DT
role  ||| S:110 E:115 ||| NN
of  ||| S:115 E:118 ||| IN
probe  ||| S:118 E:124 ||| NN
spacing  ||| S:124 E:132 ||| NNS
and  ||| S:132 E:136 ||| CC
measurement  ||| S:136 E:148 ||| JJ
site  ||| S:148 E:153 ||| NN
studied  ||| S:153 E:161 ||| VBN
in  ||| S:161 E:164 ||| IN
healthy  ||| S:164 E:172 ||| JJ
volunteers  ||| S:172 E:183 ||| NNS
To  ||| S:183 E:186 ||| TO
assess  ||| S:186 E:193 ||| VB
potential  ||| S:193 E:203 ||| JJ
metabolic  ||| S:203 E:213 ||| NN
and  ||| S:213 E:217 ||| CC
microcirculatory  ||| S:217 E:234 ||| JJ
alterations  ||| S:234 E:246 ||| NN
in  ||| S:246 E:249 ||| IN
critically  ||| S:249 E:260 ||| RB
ill  ||| S:260 E:264 ||| JJ
patients ||| S:264 E:272 ||| NNS
,  ||| S:272 E:274 ||| ,
near-infrared  ||| S:274 E:288 ||| JJ
spectroscopy  ||| S:288 E:301 ||| NNS
( ||| S:301 E:302 ||| -LRB-
NIRS ||| S:302 E:306 ||| NNP
)  ||| S:306 E:308 ||| -RRB-
has  ||| S:308 E:312 ||| VBZ
been  ||| S:312 E:317 ||| VBN
used ||| S:317 E:321 ||| VBN
,  ||| S:321 E:323 ||| ,
in  ||| S:323 E:326 ||| IN
combination  ||| S:326 E:338 ||| NN
with  ||| S:338 E:343 ||| IN
a  ||| S:343 E:345 ||| DT
vascular  ||| S:345 E:354 ||| JJ
occlusion  ||| S:354 E:364 ||| JJ
test  ||| S:364 E:369 ||| NN
( ||| S:369 E:370 ||| -LRB-
VOT ||| S:370 E:373 ||| NNP
) ||| S:373 E:374 ||| -RRB-
,  ||| S:374 E:376 ||| ,
for  ||| S:376 E:380 ||| IN
the  ||| S:380 E:384 ||| DT
non-invasive  ||| S:384 E:397 ||| JJ
measurement  ||| S:397 E:409 ||| NN
of  ||| S:409 E:412 ||| IN
tissue  ||| S:412 E:419 ||| NN
oxygen  ||| S:419 E:426 ||| NN
saturation  ||| S:426 E:437 ||| NNS
( ||| S:437 E:438 ||| -LRB-
StO2 ||| S:438 E:442 ||| NNP
) ||| S:442 E:443 ||| -RRB-
,  ||| S:443 E:445 ||| ,
oxygen  ||| S:445 E:452 ||| JJ
consumption ||| S:452 E:463 ||| NN
,  ||| S:463 E:465 ||| ,
and  ||| S:465 E:469 ||| CC
microvascular  ||| S:469 E:483 ||| JJ
reperfusion  ||| S:483 E:495 ||| NN
and  ||| S:495 E:499 ||| CC
reactivity ||| S:499 E:509 ||| NN
.  ||| S:509 E:511 ||| .
The  ||| S:511 E:515 ||| DT
methodologies  ||| S:515 E:529 ||| NN
for  ||| S:529 E:533 ||| IN
assessing  ||| S:533 E:543 ||| VBG
StO2  ||| S:543 E:548 ||| NN
during  ||| S:548 E:555 ||| IN
a  ||| S:555 E:557 ||| DT
VOT ||| S:557 E:560 ||| NNP
,  ||| S:560 E:562 ||| ,
however ||| S:562 E:569 ||| RB
,  ||| S:569 E:571 ||| ,
are  ||| S:571 E:575 ||| VBP
very  ||| S:575 E:580 ||| RB
inconsistent  ||| S:580 E:593 ||| VBN
in  ||| S:593 E:596 ||| IN
the  ||| S:596 E:600 ||| DT
literature  ||| S:600 E:611 ||| NN
and ||| S:611 E:614 ||| CC
,  ||| S:614 E:616 ||| ,
consequently ||| S:616 E:628 ||| RB
,  ||| S:628 E:630 ||| ,
results  ||| S:630 E:638 ||| NNS
vary  ||| S:638 E:643 ||| VBP
from  ||| S:643 E:648 ||| IN
study  ||| S:648 E:654 ||| NN
to  ||| S:654 E:657 ||| TO
study ||| S:657 E:662 ||| VB
,  ||| S:662 E:664 ||| ,
making  ||| S:664 E:671 ||| VBG
data  ||| S:671 E:676 ||| NNS
comparison  ||| S:676 E:687 ||| VBP
difficult  ||| S:687 E:697 ||| JJ
and  ||| S:697 E:701 ||| CC
potentially  ||| S:701 E:713 ||| RB
inadequate ||| S:713 E:723 ||| JJ
.  ||| S:723 E:725 ||| .
Two  ||| S:725 E:729 ||| CD
major  ||| S:729 E:735 ||| JJ
aspects  ||| S:735 E:743 ||| NNS
concerning  ||| S:743 E:754 ||| VBG
the  ||| S:754 E:758 ||| DT
inconsistent  ||| S:758 E:771 ||| JJ
methodology  ||| S:771 E:783 ||| NNS
are  ||| S:783 E:787 ||| VBP
measurement  ||| S:787 E:799 ||| JJ
site  ||| S:799 E:804 ||| NN
and  ||| S:804 E:808 ||| CC
probe  ||| S:808 E:814 ||| NN
spacing ||| S:814 E:821 ||| NN
.  ||| S:821 E:823 ||| .
To  ||| S:823 E:826 ||| TO
address  ||| S:826 E:834 ||| VB
these  ||| S:834 E:840 ||| DT
issues ||| S:840 E:846 ||| NNS
,  ||| S:846 E:848 ||| ,
we  ||| S:848 E:851 ||| PRP
investigated  ||| S:851 E:864 ||| VBD
the  ||| S:864 E:868 ||| DT
effects  ||| S:868 E:876 ||| NNS
of  ||| S:876 E:879 ||| IN
probe  ||| S:879 E:885 ||| NN
spacing  ||| S:885 E:893 ||| NNS
and  ||| S:893 E:897 ||| CC
measurement  ||| S:897 E:909 ||| JJ
site  ||| S:909 E:914 ||| NN
using  ||| S:914 E:920 ||| VBG
15  ||| S:920 E:923 ||| CD
mm  ||| S:923 E:926 ||| NNS
and  ||| S:926 E:930 ||| CC
25  ||| S:930 E:933 ||| CD
mm  ||| S:933 E:936 ||| JJ
probe  ||| S:936 E:942 ||| NN
spacings  ||| S:942 E:951 ||| NN
on  ||| S:951 E:954 ||| IN
the  ||| S:954 E:958 ||| DT
thenar  ||| S:958 E:965 ||| NN
and  ||| S:965 E:969 ||| CC
the  ||| S:969 E:973 ||| DT
forearm  ||| S:973 E:981 ||| NN
in  ||| S:981 E:984 ||| IN
healthy  ||| S:984 E:992 ||| JJ
volunteers  ||| S:992 E:1003 ||| NNS
and  ||| S:1003 E:1007 ||| CC
quantified  ||| S:1007 E:1018 ||| JJ
baseline ||| S:1018 E:1026 ||| NN
,  ||| S:1026 E:1028 ||| ,
ischemic ||| S:1028 E:1036 ||| NN
,  ||| S:1036 E:1038 ||| ,
reperfusion ||| S:1038 E:1049 ||| NN
,  ||| S:1049 E:1051 ||| ,
and  ||| S:1051 E:1055 ||| CC
hyperemic  ||| S:1055 E:1065 ||| JJ
VOT-derived  ||| S:1065 E:1077 ||| JJ
StO2  ||| S:1077 E:1082 ||| CD
variables ||| S:1082 E:1091 ||| NNS
.  ||| S:1091 E:1093 ||| .
StO2  ||| S:1093 E:1098 ||| NNP
was  ||| S:1098 E:1102 ||| VBD
non-invasively  ||| S:1102 E:1117 ||| JJ
measured  ||| S:1117 E:1126 ||| VBN
in  ||| S:1126 E:1129 ||| IN
the  ||| S:1129 E:1133 ||| DT
forearm  ||| S:1133 E:1141 ||| NN
and  ||| S:1141 E:1145 ||| CC
thenar  ||| S:1145 E:1152 ||| NN
in  ||| S:1152 E:1155 ||| IN
eight  ||| S:1155 E:1161 ||| CD
healthy  ||| S:1161 E:1169 ||| JJ
volunteers  ||| S:1169 E:1180 ||| NNS
during  ||| S:1180 E:1187 ||| IN
3-minute  ||| S:1187 E:1196 ||| CD
VOTs  ||| S:1196 E:1201 ||| JJ
using  ||| S:1201 E:1207 ||| VBG
two  ||| S:1207 E:1211 ||| CD
InSpectra  ||| S:1211 E:1221 ||| JJ
tissue  ||| S:1221 E:1228 ||| NN
spectrometers  ||| S:1228 E:1242 ||| VBZ
equipped  ||| S:1242 E:1251 ||| VBN
with  ||| S:1251 E:1256 ||| IN
a  ||| S:1256 E:1258 ||| DT
15  ||| S:1258 E:1261 ||| CD
mm  ||| S:1261 E:1264 ||| JJ
probe  ||| S:1264 E:1270 ||| NN
or  ||| S:1270 E:1273 ||| CC
a  ||| S:1273 E:1275 ||| DT
25  ||| S:1275 E:1278 ||| CD
mm  ||| S:1278 E:1281 ||| JJ
probe ||| S:1281 E:1286 ||| NN
.  ||| S:1286 E:1288 ||| .
VOT-derived  ||| S:1288 E:1300 ||| JJ
StO2  ||| S:1300 E:1305 ||| CD
traces  ||| S:1305 E:1312 ||| NNS
were  ||| S:1312 E:1317 ||| VBD
analyzed  ||| S:1317 E:1326 ||| VBN
for  ||| S:1326 E:1330 ||| IN
base-line ||| S:1330 E:1339 ||| NNP
,  ||| S:1339 E:1341 ||| ,
ischemic ||| S:1341 E:1349 ||| NN
,  ||| S:1349 E:1351 ||| ,
reperfusion ||| S:1351 E:1362 ||| NN
,  ||| S:1362 E:1364 ||| ,
and  ||| S:1364 E:1368 ||| CC
hyperemic  ||| S:1368 E:1378 ||| JJ
parameters ||| S:1378 E:1388 ||| NNS
.  ||| S:1388 E:1390 ||| .
Data  ||| S:1390 E:1395 ||| NNP
were  ||| S:1395 E:1400 ||| VBD
categorized  ||| S:1400 E:1412 ||| VBN
into  ||| S:1412 E:1417 ||| IN
four  ||| S:1417 E:1422 ||| CD
groups ||| S:1422 E:1428 ||| NNS
:  ||| S:1428 E:1430 ||| :
15  ||| S:1430 E:1433 ||| CD
mm  ||| S:1433 E:1436 ||| JJ
probe  ||| S:1436 E:1442 ||| NN
on  ||| S:1442 E:1445 ||| IN
the  ||| S:1445 E:1449 ||| DT
forearm  ||| S:1449 E:1457 ||| NN
( ||| S:1457 E:1458 ||| -LRB-
F15  ||| S:1458 E:1462 ||| FW
mm ||| S:1462 E:1464 ||| FW
) ||| S:1464 E:1465 ||| -RRB-
,  ||| S:1465 E:1467 ||| ,
25  ||| S:1467 E:1470 ||| CD
mm  ||| S:1470 E:1473 ||| JJ
probe  ||| S:1473 E:1479 ||| NN
on  ||| S:1479 E:1482 ||| IN
the  ||| S:1482 E:1486 ||| DT
forearm  ||| S:1486 E:1494 ||| NN
( ||| S:1494 E:1495 ||| -LRB-
F25  ||| S:1495 E:1499 ||| FW
mm ||| S:1499 E:1501 ||| FW
) ||| S:1501 E:1502 ||| -RRB-
,  ||| S:1502 E:1504 ||| ,
15  ||| S:1504 E:1507 ||| CD
mm  ||| S:1507 E:1510 ||| JJ
probe  ||| S:1510 E:1516 ||| NN
on  ||| S:1516 E:1519 ||| IN
the  ||| S:1519 E:1523 ||| DT
thenar  ||| S:1523 E:1530 ||| NN
( ||| S:1530 E:1531 ||| -LRB-
T15  ||| S:1531 E:1535 ||| FW
mm ||| S:1535 E:1537 ||| FW
) ||| S:1537 E:1538 ||| -RRB-
,  ||| S:1538 E:1540 ||| ,
and  ||| S:1540 E:1544 ||| CC
25  ||| S:1544 E:1547 ||| CD
mm  ||| S:1547 E:1550 ||| JJ
probe  ||| S:1550 E:1556 ||| NN
on  ||| S:1556 E:1559 ||| IN
the  ||| S:1559 E:1563 ||| DT
thenar  ||| S:1563 E:1570 ||| NN
( ||| S:1570 E:1571 ||| -LRB-
T25  ||| S:1571 E:1575 ||| FW
mm ||| S:1575 E:1577 ||| FW
) ||| S:1577 E:1578 ||| -RRB-
.  ||| S:1578 E:1580 ||| .
Although  ||| S:1580 E:1589 ||| IN
not  ||| S:1589 E:1593 ||| RB
apparent  ||| S:1593 E:1602 ||| JJ
at  ||| S:1602 E:1605 ||| IN
baseline ||| S:1605 E:1613 ||| NN
,  ||| S:1613 E:1615 ||| ,
probe  ||| S:1615 E:1621 ||| NN
spacing  ||| S:1621 E:1629 ||| NNS
and  ||| S:1629 E:1633 ||| CC
measurement  ||| S:1633 E:1645 ||| JJ
site  ||| S:1645 E:1650 ||| NN
significantly  ||| S:1650 E:1664 ||| RB
influenced  ||| S:1664 E:1675 ||| VBN
VOT-derived  ||| S:1675 E:1687 ||| JJ
StO2  ||| S:1687 E:1692 ||| CD
variables ||| S:1692 E:1701 ||| NNS
.  ||| S:1701 E:1703 ||| .
For  ||| S:1703 E:1707 ||| IN
F15  ||| S:1707 E:1711 ||| CD
mm ||| S:1711 E:1713 ||| NN
,  ||| S:1713 E:1715 ||| ,
F25  ||| S:1715 E:1719 ||| CD
mm ||| S:1719 E:1721 ||| NN
,  ||| S:1721 E:1723 ||| ,
T15  ||| S:1723 E:1727 ||| CD
mm ||| S:1727 E:1729 ||| NN
,  ||| S:1729 E:1731 ||| ,
and  ||| S:1731 E:1735 ||| CC
T25  ||| S:1735 E:1739 ||| CD
mm ||| S:1739 E:1741 ||| NN
,  ||| S:1741 E:1743 ||| ,
StO2  ||| S:1743 E:1748 ||| CD
ownslope  ||| S:1748 E:1757 ||| NNS
was  ||| S:1757 E:1761 ||| VBD
-6.4  ||| S:1761 E:1766 ||| CD
+ ||| S:1766 E:1767 ||| CD
/ ||| S:1767 E:1768 ||| CD
-  ||| S:1768 E:1770 ||| :
1.7 ||| S:1770 E:1773 ||| CD
% ||| S:1773 E:1774 ||| NN
/ ||| S:1774 E:1775 ||| CD
minute ||| S:1775 E:1781 ||| NN
,  ||| S:1781 E:1783 ||| ,
-10.0  ||| S:1783 E:1789 ||| NNP
+ ||| S:1789 E:1790 ||| NNP
/ ||| S:1790 E:1791 ||| NNP
-  ||| S:1791 E:1793 ||| :
3.2 ||| S:1793 E:1796 ||| CD
% ||| S:1796 E:1797 ||| NN
/ ||| S:1797 E:1798 ||| CD
minute ||| S:1798 E:1804 ||| NN
,  ||| S:1804 E:1806 ||| ,
-12.5  ||| S:1806 E:1812 ||| NNP
+ ||| S:1812 E:1813 ||| NNP
/ ||| S:1813 E:1814 ||| NNP
-  ||| S:1814 E:1816 ||| :
3.0 ||| S:1816 E:1819 ||| CD
% ||| S:1819 E:1820 ||| NN
/ ||| S:1820 E:1821 ||| CD
minute ||| S:1821 E:1827 ||| NN
,  ||| S:1827 E:1829 ||| ,
and  ||| S:1829 E:1833 ||| CC
-36.7  ||| S:1833 E:1839 ||| CD
+ ||| S:1839 E:1840 ||| CD
/ ||| S:1840 E:1841 ||| CD
-  ||| S:1841 E:1843 ||| :
4.6 ||| S:1843 E:1846 ||| CD
% ||| S:1846 E:1847 ||| NN
/ ||| S:1847 E:1848 ||| CD
minute ||| S:1848 E:1854 ||| NN
,  ||| S:1854 E:1856 ||| ,
respectively ||| S:1856 E:1868 ||| RB
.  ||| S:1868 E:1870 ||| .
StO2  ||| S:1870 E:1875 ||| NNP
upslope  ||| S:1875 E:1883 ||| NN
was  ||| S:1883 E:1887 ||| VBD
105  ||| S:1887 E:1891 ||| CD
+ ||| S:1891 E:1892 ||| CD
/ ||| S:1892 E:1893 ||| CD
-  ||| S:1893 E:1895 ||| :
34 ||| S:1895 E:1897 ||| CD
% ||| S:1897 E:1898 ||| NN
/ ||| S:1898 E:1899 ||| CD
minute ||| S:1899 E:1905 ||| NN
,  ||| S:1905 E:1907 ||| ,
158  ||| S:1907 E:1911 ||| CD
+ ||| S:1911 E:1912 ||| CD
/ ||| S:1912 E:1913 ||| CD
-  ||| S:1913 E:1915 ||| :
55 ||| S:1915 E:1917 ||| CD
% ||| S:1917 E:1918 ||| NN
/ ||| S:1918 E:1919 ||| CD
minute ||| S:1919 E:1925 ||| NN
,  ||| S:1925 E:1927 ||| ,
226  ||| S:1927 E:1931 ||| CD
+ ||| S:1931 E:1932 ||| CD
/ ||| S:1932 E:1933 ||| CD
-  ||| S:1933 E:1935 ||| :
41 ||| S:1935 E:1937 ||| CD
% ||| S:1937 E:1938 ||| NN
/ ||| S:1938 E:1939 ||| CD
minute ||| S:1939 E:1945 ||| NN
,  ||| S:1945 E:1947 ||| ,
and  ||| S:1947 E:1951 ||| CC
713  ||| S:1951 E:1955 ||| CD
+ ||| S:1955 E:1956 ||| CD
/ ||| S:1956 E:1957 ||| CD
-  ||| S:1957 E:1959 ||| :
101 ||| S:1959 E:1962 ||| CD
% ||| S:1962 E:1963 ||| NN
/ ||| S:1963 E:1964 ||| CD
minute ||| S:1964 E:1970 ||| NN
,  ||| S:1970 E:1972 ||| ,
and  ||| S:1972 E:1976 ||| CC
the  ||| S:1976 E:1980 ||| DT
area  ||| S:1980 E:1985 ||| NN
under  ||| S:1985 E:1991 ||| IN
the  ||| S:1991 E:1995 ||| DT
hyperemic  ||| S:1995 E:2005 ||| JJ
curve  ||| S:2005 E:2011 ||| NN
was  ||| S:2011 E:2015 ||| VBD
7.4  ||| S:2015 E:2019 ||| CD
+ ||| S:2019 E:2020 ||| CD
/ ||| S:2020 E:2021 ||| CD
-  ||| S:2021 E:2023 ||| :
3.8 ||| S:2023 E:2026 ||| CD
% ||| S:2026 E:2027 ||| NN
.minute ||| S:2027 E:2034 ||| NN
,  ||| S:2034 E:2036 ||| ,
10.1  ||| S:2036 E:2041 ||| CD
+ ||| S:2041 E:2042 ||| CD
/ ||| S:2042 E:2043 ||| CD
-  ||| S:2043 E:2045 ||| :
4.9 ||| S:2045 E:2048 ||| CD
% ||| S:2048 E:2049 ||| NN
.minute ||| S:2049 E:2056 ||| NN
,  ||| S:2056 E:2058 ||| ,
12.6  ||| S:2058 E:2063 ||| CD
+ ||| S:2063 E:2064 ||| CD
/ ||| S:2064 E:2065 ||| CD
-  ||| S:2065 E:2067 ||| :
4.4 ||| S:2067 E:2070 ||| CD
% ||| S:2070 E:2071 ||| NN
.minute ||| S:2071 E:2078 ||| NN
,  ||| S:2078 E:2080 ||| ,
and  ||| S:2080 E:2084 ||| CC
21.2  ||| S:2084 E:2089 ||| CD
+ ||| S:2089 E:2090 ||| CD
/ ||| S:2090 E:2091 ||| CD
-  ||| S:2091 E:2093 ||| :
2.7 ||| S:2093 E:2096 ||| CD
% ||| S:2096 E:2097 ||| NN
.minute  ||| S:2097 E:2105 ||| NN
in  ||| S:2105 E:2108 ||| IN
these  ||| S:2108 E:2114 ||| DT
groups ||| S:2114 E:2120 ||| NNS
,  ||| S:2120 E:2122 ||| ,
respectively ||| S:2122 E:2134 ||| RB
.  ||| S:2134 E:2136 ||| .
Furthermore ||| S:2136 E:2147 ||| RB
,  ||| S:2147 E:2149 ||| ,
the  ||| S:2149 E:2153 ||| DT
StO2  ||| S:2153 E:2158 ||| CD
parameters  ||| S:2158 E:2169 ||| NNS
of  ||| S:2169 E:2172 ||| IN
the  ||| S:2172 E:2176 ||| DT
hyperemic  ||| S:2176 E:2186 ||| JJ
phase  ||| S:2186 E:2192 ||| NN
of  ||| S:2192 E:2195 ||| IN
the  ||| S:2195 E:2199 ||| DT
VOT ||| S:2199 E:2202 ||| NNP
,  ||| S:2202 E:2204 ||| ,
such  ||| S:2204 E:2209 ||| JJ
as  ||| S:2209 E:2212 ||| IN
the  ||| S:2212 E:2216 ||| DT
area  ||| S:2216 E:2221 ||| NN
under  ||| S:2221 E:2227 ||| IN
the  ||| S:2227 E:2231 ||| DT
curve ||| S:2231 E:2236 ||| NN
,  ||| S:2236 E:2238 ||| ,
significantly  ||| S:2238 E:2252 ||| RB
correlated  ||| S:2252 E:2263 ||| VBN
to  ||| S:2263 E:2266 ||| TO
the  ||| S:2266 E:2270 ||| DT
minimum  ||| S:2270 E:2278 ||| JJ
StO2  ||| S:2278 E:2283 ||| NN
during  ||| S:2283 E:2290 ||| IN
ischemia ||| S:2290 E:2298 ||| NN
.  ||| S:2298 E:2300 ||| .
NIRS  ||| S:2300 E:2305 ||| NNP
measurements  ||| S:2305 E:2318 ||| NNS
in  ||| S:2318 E:2321 ||| IN
combination  ||| S:2321 E:2333 ||| NN
with  ||| S:2333 E:2338 ||| IN
a  ||| S:2338 E:2340 ||| DT
VOT  ||| S:2340 E:2344 ||| NNP
are  ||| S:2344 E:2348 ||| VBP
measurement  ||| S:2348 E:2360 ||| JJ
site-dependent  ||| S:2360 E:2375 ||| JJ
and  ||| S:2375 E:2379 ||| CC
probe-dependent ||| S:2379 E:2394 ||| JJ
.  ||| S:2394 E:2396 ||| .
Whether  ||| S:2396 E:2404 ||| IN
this  ||| S:2404 E:2409 ||| DT
dependence  ||| S:2409 E:2420 ||| NN
is  ||| S:2420 E:2423 ||| VBZ
anatomy- ||| S:2423 E:2431 ||| JJ
,  ||| S:2431 E:2433 ||| ,
physiology- ||| S:2433 E:2444 ||| NNP
,  ||| S:2444 E:2446 ||| ,
or  ||| S:2446 E:2449 ||| CC
perhaps  ||| S:2449 E:2457 ||| RB
technology-related  ||| S:2457 E:2476 ||| JJ
remains  ||| S:2476 E:2484 ||| VBZ
to  ||| S:2484 E:2487 ||| TO
be  ||| S:2487 E:2490 ||| VB
elucidated ||| S:2490 E:2500 ||| NNS
.  ||| S:2500 E:2502 ||| .
Our  ||| S:2502 E:2506 ||| PRP$
study  ||| S:2506 E:2512 ||| NN
also  ||| S:2512 E:2517 ||| RB
indicated  ||| S:2517 E:2527 ||| VBN
that  ||| S:2527 E:2532 ||| IN
reactive  ||| S:2532 E:2541 ||| JJ
hyperemia  ||| S:2541 E:2551 ||| NN
depends  ||| S:2551 E:2559 ||| VBZ
on  ||| S:2559 E:2562 ||| IN
the  ||| S:2562 E:2566 ||| DT
extent  ||| S:2566 E:2573 ||| NN
of  ||| S:2573 E:2576 ||| IN
ischemic  ||| S:2576 E:2585 ||| JJ
insult ||| S:2585 E:2591 ||| NN
.  ||| S:2591 E:2593 ||| .
